Continuous Glucose Monitoring Guidelines | Safer Everyday Decisions

Safe daily use of CGM means wearing it most of the time, aiming for steady time in range, and acting on trends with your care team.

Continuous glucose monitoring, or CGM, has moved from specialist clinics into daily life for many people living with diabetes. Sensors now sit under clothing, send readings to a phone or handheld reader, and turn raw numbers into patterns you can use. Clear guidelines help turn that stream of data into calmer days, fewer surprises, and safer glucose control.

This guide brings together core points from major diabetes organisations so you can see how recommended practice looks in day-to-day life. It does not replace advice from your own diabetes clinic, yet it can help you arrive at appointments with better questions and a clearer sense of what steady CGM use should deliver.

How Continuous Glucose Monitoring Works

A CGM system uses a tiny filament inserted under the skin, usually on the abdomen or upper arm. The sensor reads glucose in the fluid between cells every few minutes and sends that information to a receiver, smartphone, or insulin pump. You see a current reading, arrows that show direction of change, and a graph of the past several hours or days.

Most systems have a warm-up period after insertion before data appears on your screen. Some models need periodic calibration with a finger-stick meter, while others work from factory calibration only. Sensors are worn for a set number of days, then replaced. The exact wear time depends on the brand, so following the device instructions matters for accuracy and safety.

Because CGM measures interstitial fluid, not blood directly, readings can lag behind finger-stick values by several minutes, especially when glucose is rising or falling quickly. For that reason, major bodies such as the National Institute of Diabetes and Digestive and Kidney Diseases advise checking with a meter when readings look odd or symptoms do not match the number on your screen.

Continuous Glucose Monitoring Guidelines For Everyday Use

Across guidelines from the American Diabetes Association, the Endocrine Society diabetes technology guideline, and national health services, a few themes repeat. CGM is strongly recommended for most people with type 1 diabetes and for many people with type 2 diabetes who use multiple daily insulin injections or pumps. Real-time data, especially overnight and between meals, helps reduce both low and high glucose episodes.

Professional groups also underline that CGM makes the most sense when used consistently. Data summaries are most reliable when the sensor is active at least seventy percent of the time across about two weeks of wear. That level of use gives a realistic picture of daily life, including sleep, workdays, weekends, and exercise.

Guidelines now talk not only about single glucose readings but about “time in range.” For many non-pregnant adults with diabetes, a common target range is 70 to 180 mg/dL (3.9 to 10 mmol/L). Instead of staring at each point on the graph, teams look at the percentage of readings inside, below, and above that band, then set goals that match the person’s age, complication risk, and risk of low glucose.

CGM Metric	Typical Target For Many Adults	Notes
Time in range 70–180 mg/dL	≥ 70% of readings	Common goal with A1c near 7%.
Time below 70 mg/dL	< 4%	Guard against frequent lows.
Time below 54 mg/dL	< 1%	Avoid prolonged severe lows.
Time above 180 mg/dL	< 25%	Limit long periods of highs.
Time above 250 mg/dL	< 5%	Keep highest spikes infrequent.
Mean glucose	Aligned with agreed HbA1c goal	Based on at least 14 days.
Glucose management indicator (GMI)	Close to lab HbA1c	Mismatch may signal other issues.
Sensor wear time	≥ 70% of the time	Needed for a reliable report.

These figures come from joint statements and a clinical targets overview for CGM reports. They give a starting point, not a fixed rule for every person. Children, pregnant people, older adults, and those with frequent severe lows need individualised plans that shape time-in-range goals and alarm thresholds.

National health bodies also stress that CGM access should be equitable, and documents such as the NICE quality statement on CGM point in that direction. In many regions, adults and children with type 1 diabetes are entitled to continuous glucose monitoring or flash sensors as part of standard care. People with type 2 diabetes who use intensive insulin regimens may qualify when they face frequent lows, need checking many times a day, or live with disabilities that make finger-stick testing hard.

Starting Continuous Glucose Monitoring Safely

Before placing a first sensor, most guidelines advise a focused conversation with the diabetes team. That discussion usually covers goals, preferred targets, alarm settings, device choice, and how CGM readings will feed into medication and lifestyle changes. Funding rules, smartphone access, and personal preferences all play a part in the final choice of device.

Early weeks can feel noisy, with fresh alerts and graphs to interpret. Instead of changing doses with every spike or dip, teams often encourage people to look at patterns over several days. For example, repeated rises after the same evening meal may point toward dose timing, portion size, or medication review, while daily dawn spikes might raise questions about overnight basal insulin.

Daily Habits That Match CGM Guidance

Once CGM becomes familiar, small routines keep the data reliable. Rotating insertion sites limits scarring and helps readings stay close to capillary values. Checking that phone Bluetooth or receiver batteries are charged reduces signal gaps. Many services suggest a quick glance at the trend line before meals, at bedtime, and before driving, with extra checks during exercise or illness.

Time-in-range reports sit at the centre of many current standards, and the American Diabetes Association CGM & Time in Range page sets widely used targets. Studies linking CGM summaries with HbA1c show that higher time in range often tracks with lower average glucose and fewer complications. Clinics now use those summaries alongside lab tests, not as separate worlds.

Alerts need a steady approach as well. Low alerts should prompt fast-acting carbohydrate and a repeat check, whether with the sensor or a meter, based on the advice you have agreed locally. High alerts might call for a correction bolus, movement, hydration, or simply patience when insulin has already been given. Acting on every single blip can create swings, so context always matters.

Common CGM Problems And Practical Fixes

Even with careful use, sensors create occasional puzzles. The issues below come up often in clinics and diabetes education sessions.

Issue	What It Often Means	What You Can Try
Sensor reads low but you feel fine	Pressure on the sensor or fast glucose change.	Relieve pressure, wash hands, and confirm with a meter.
Large gap between CGM and finger-stick value	Warm-up, pressure, or sensor near expiry.	Recheck after a few minutes and follow device guidance on calibration or replacement.
Frequent signal loss	Phone out of range, Bluetooth off, or app not running.	Keep the receiver nearby, reopen the app, and check phone and battery settings.
Skin irritation under patch	Sensitivity to adhesive or moisture under the sensor.	Use approved barrier wipes, let skin dry fully, and rotate sites.
Alarms going off overnight	Targets or alert thresholds set too tight, or bedtime glucose running low.	Agree on changes to alert ranges, basal rates, or evening snacks with your diabetes clinic.
Data overwhelm	Graphs and numbers feel hard to interpret.	Bring downloads to appointments and ask staff to walk through one example day.

Device manuals give brand-specific instructions, yet most services also share simple troubleshooting charts like the one above. Repeated problems, sensor failures, or skin reactions should always be raised with a professional team, as alternative devices or extra skin care steps may help.

Who Should Use Continuous Glucose Monitoring And When

Current guidelines draw lines around who should be offered CGM as part of routine care. Adults and children with type 1 diabetes are high on that list, because they live with daily insulin dependence and a high lifetime risk of both lows and long-term complications. National guidance in several countries states that this group should have access to real-time CGM or flash systems through public or insurance funding.

Many people with type 2 diabetes also benefit, especially those using basal-bolus insulin regimens, those with recurrent severe hypoglycaemia, and those who need to check frequently for work, driving, pregnancy, or high-risk sports. Some services now offer periodic professional CGM for people who do not use insulin, to map patterns before major treatment changes.

Alongside clinical need, practical factors shape decisions. Access to compatible smartphones, comfort with apps, work rules around devices, and local funding arrangements all influence who receives sensors and which models are chosen. Equity remains a concern, since studies still find lower prescribing rates in some ethnic groups and deprived areas, even where national guidance backs CGM access.

Making Guidelines Work In Everyday Life

CGM guidance on paper turns into benefits only when numbers and graphs feed into small, steady adjustments. Many clinics encourage people to pick one focus for each visit, such as cutting down time below range overnight, smoothing post-breakfast spikes, or widening alert thresholds to cut alarm fatigue. Linking those goals to the metrics in your CGM report keeps efforts measurable.

Finally, CGM works best as one tool among many. Counting carbohydrates, adjusting insulin, staying active, and taking other medications as prescribed still form the base of diabetes care. Continuous data simply brings hidden trends into view so that each of those pieces can be adjusted more safely. Used in line with current guidance, CGM can help with steadier glucose control, fewer emergency visits, and more confidence in everyday decisions.